FDA.reportPublic FDA data

LINAGLIPTIN

Substance profile for UNII 3X29ZEJ4R2, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for LINAGLIPTIN
Structure render from PubChem CID 10096344

Substance Identity#

UNII
3X29ZEJ4R2
Preferred term
LINAGLIPTIN
Registry number
668270-12-0
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C25H28N8O2
Chemical structure for LINAGLIPTIN
Structure render from PubChem CID 10096344

Chemical And Database Identifiers#

InChIKey
LTXREWYXXSTFRX-QGZVFWFLSA-N
SMILES
CC#CCN1C(=NC2=C1C(=O)N(CC3=NC4=CC=CC=C4C(C)=N3)C(=O)N2C)N5CCC[C@@H](N)C5
RxCUI
1100699
PubChem
10096344
NCIt
C83887
INN ID
9039

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound10096344https://pubchem.ncbi.nlm.nih.gov/compound/10096344
PubChem InChIKey SearchLTXREWYXXSTFRX-QGZVFWFLSA-Nhttps://pubchem.ncbi.nlm.nih.gov/#query=LTXREWYXXSTFRX-QGZVFWFLSA-N
RxNorm1100699https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1100699
NCI ThesaurusC83887https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C83887
FDA Substance Registration System3X29ZEJ4R2https://precision.fda.gov/uniisearch/srs/unii/3X29ZEJ4R2

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
linagliptinACTIVE INGREDIENT3X29ZEJ4R2These highlights do not include all the information needed to use JENTADUETO safely and effectively. See full prescribing information for JENTADUETO. Jentadueto ® (linagliptin and metformin hydrochloride) tablets Initial U.S. Approval: 20122
linagliptinACTIVE MOIETY3X29ZEJ4R2These highlights do not include all the information needed to use JENTADUETO safely and effectively. See full prescribing information for JENTADUETO. Jentadueto ® (linagliptin and metformin hydrochloride) tablets Initial U.S. Approval: 20122
linagliptinACTIVE MOIETY3X29ZEJ4R2JENTADUETO (LINAGLIPTIN) TABLET, FILM COATED [BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.]28
linagliptinACTIVE INGREDIENT3X29ZEJ4R2JENTADUETO (LINAGLIPTIN) TABLET, FILM COATED [BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.]28
linagliptinACTIVE MOIETY3X29ZEJ4R2TRADJENTA (LINAGLIPTIN) TABLET, FILM COATED [BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.]20
linagliptinACTIVE INGREDIENT3X29ZEJ4R2TRADJENTA (LINAGLIPTIN) TABLET, FILM COATED [BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.]20
linagliptinACTIVE MOIETY3X29ZEJ4R2GLYXAMBI (EMPAGLIFLOZIN LINAGLIPTIN) TABLET, FILM COATED [BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.]2
linagliptinACTIVE INGREDIENT3X29ZEJ4R2GLYXAMBI (EMPAGLIFLOZIN LINAGLIPTIN) TABLET, FILM COATED [BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.]2
linagliptinACTIVE INGREDIENT3X29ZEJ4R2TRADJENTA (LINAGLIPTIN) TABLET, FILM COATED [CARDINAL HEALTH]1
linagliptinACTIVE MOIETY3X29ZEJ4R2TRADJENTA (LINAGLIPTIN) TABLET, FILM COATED [CARDINAL HEALTH]1